Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. QQQ
8. LDOS
9. HUM
10. CSCO

Go back to Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial Results

Sangamo Therapeutics (SGMO) Misses Q1 EPS by 8c

May 11, 2020 4:01 PM EDT

Sangamo Therapeutics (NASDAQ: SGMO) reported Q1 EPS of ($0.37), $0.08 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $22.74 million.

Im proud of how the Sangamo team has worked together through the unusual circumstances presented by the... More